Related Experiment Video
Updated: Apr 20, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings
Jeannette Parkes1, Marc Hendricks, Peter Ssenyonga
1Department of Radiation Oncology, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Insights
Effective medulloblastoma treatment in children requires specialized multidisciplinary teams and facilities. This article offers management guidelines for standard-risk pediatric medulloblastoma based on available resources, especially for low and middle-income countries.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Global Health
Background:
- Medulloblastoma treatment necessitates comprehensive multidisciplinary teams and advanced facilities.
- Resource limitations in low and middle-income countries (LMICs) hinder effective pediatric medulloblastoma care.
- Tumor and treatment-related complications require specialized screening and management capabilities.
Purpose of the Study:
- To provide evidence-based management recommendations for standard-risk pediatric medulloblastoma.
- To tailor treatment strategies according to available healthcare infrastructure in different settings.
- To improve outcomes for children with medulloblastoma, particularly in resource-limited environments.
Main Methods:
- Review of existing literature and clinical guidelines for medulloblastoma management.
- Development of tiered recommendations based on facility capabilities (neurosurgery, radiology, pathology, radiotherapy, chemotherapy).
- Focus on standard-risk medulloblastoma in children aged over 3-5 years with localized tumors.
Main Results:
- Guidelines are stratified based on the availability of essential multidisciplinary services.
- Recommendations address the management of localized, standard-risk medulloblastoma.
- Strategies are adaptable to varying levels of healthcare resources.
Conclusions:
- Accessible, tiered management protocols can optimize pediatric medulloblastoma treatment globally.
- Adapting care to local resources is crucial for improving outcomes in LMICs.
- Multidisciplinary collaboration and resource optimization are key to effective pediatric neuro-oncology care.
Abstract:
Effective treatment of children with medulloblastoma requires a functioning multi-disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition the treating centre should have the capacity to effectively screen and manage any tumour and treatment-associated complications. These requirements have made it difficult for many low and middle-income countries (LMIC) centres to offer curative treatment. This article provides management recommendations for children with standard-risk medulloblastoma (localised tumours in children over the age of 3-5 years) according to the level of facilities available.
Related Concept Videos
02:56Treatment Resistent Cancers
02:56Treatment Resistant Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...